Penicillin conversion
Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Demain, Arnold L Cho, Hiroshi Piret, Jacqueline M Adrio, Josè L Fernandez, Maria-Josefa E Bàez-Vàsquez, Marco A Hintermann, Gilberto |
description | Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see
) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG.
).
The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06383773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06383773</sourcerecordid><originalsourceid>FETCH-uspatents_grants_063837733</originalsourceid><addsrcrecordid>eNrjZBANSM3LTM7MycnMU0jOzytLLSrOzM_jYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM2MLY3NzYmAglAH0JImE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Penicillin conversion</title><source>USPTO Issued Patents</source><creator>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto</creator><creatorcontrib>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto ; Massachusetts Institute of Technology</creatorcontrib><description>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see
) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG.
).
The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6383773$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6383773$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Demain, Arnold L</creatorcontrib><creatorcontrib>Cho, Hiroshi</creatorcontrib><creatorcontrib>Piret, Jacqueline M</creatorcontrib><creatorcontrib>Adrio, Josè L</creatorcontrib><creatorcontrib>Fernandez, Maria-Josefa E</creatorcontrib><creatorcontrib>Bàez-Vàsquez, Marco A</creatorcontrib><creatorcontrib>Hintermann, Gilberto</creatorcontrib><creatorcontrib>Massachusetts Institute of Technology</creatorcontrib><title>Penicillin conversion</title><description>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see
) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG.
).
The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBANSM3LTM7MycnMU0jOzytLLSrOzM_jYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM2MLY3NzYmAglAH0JImE</recordid><startdate>20020507</startdate><enddate>20020507</enddate><creator>Demain, Arnold L</creator><creator>Cho, Hiroshi</creator><creator>Piret, Jacqueline M</creator><creator>Adrio, Josè L</creator><creator>Fernandez, Maria-Josefa E</creator><creator>Bàez-Vàsquez, Marco A</creator><creator>Hintermann, Gilberto</creator><scope>EFH</scope></search><sort><creationdate>20020507</creationdate><title>Penicillin conversion</title><author>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_063837733</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Demain, Arnold L</creatorcontrib><creatorcontrib>Cho, Hiroshi</creatorcontrib><creatorcontrib>Piret, Jacqueline M</creatorcontrib><creatorcontrib>Adrio, Josè L</creatorcontrib><creatorcontrib>Fernandez, Maria-Josefa E</creatorcontrib><creatorcontrib>Bàez-Vàsquez, Marco A</creatorcontrib><creatorcontrib>Hintermann, Gilberto</creatorcontrib><creatorcontrib>Massachusetts Institute of Technology</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Demain, Arnold L</au><au>Cho, Hiroshi</au><au>Piret, Jacqueline M</au><au>Adrio, Josè L</au><au>Fernandez, Maria-Josefa E</au><au>Bàez-Vàsquez, Marco A</au><au>Hintermann, Gilberto</au><aucorp>Massachusetts Institute of Technology</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Penicillin conversion</title><date>2002-05-07</date><risdate>2002</risdate><abstract>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see
) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG.
).
The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_06383773 |
source | USPTO Issued Patents |
title | Penicillin conversion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A39%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Demain,%20Arnold%20L&rft.aucorp=Massachusetts%20Institute%20of%20Technology&rft.date=2002-05-07&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06383773%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |